Durvalumab vs Valproic Acid

Durvalumab vs Valproic Acid: Overview

This comparison examines the pharmacological differences between Durvalumab and Valproic Acid.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Valproic Acid: Enhances GABA transmission and blocks sodium/calcium channels.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Valproic Acid — 9-16 hours.

Chemical Properties

Molecular Formula: Valproic Acid — C8H16O2.

Molecular Weight: Valproic Acid — 144.2110 g/mol.

Type: Durvalumab — Antibody; Valproic Acid — Small molecule.